French consensus on management of head and neck cancer surgery during COVID-19 pandemic |
| |
| Affiliation: | 1. Department of otorhinolaryngology, head and neck surgery, centre hospitalier universitaire (CHU) la Conception, Aix Marseille université, Assistance publique–Hôpitaux de Marseille, Marseille, France;2. Department of otorhinolaryngology, head and neck surgery, CHU, Strasbourg, France;3. Department of otorhinolaryngology, head and neck surgery, CHU, Tours, France;4. Department of otorhinolaryngology, head and neck surgery, institut Gustave-Roussy, Villejuif, France;5. Department of otorhinolaryngology, head and neck surgery, centre Antoine-Lacassagne, Institut universitaire de la face et du cou, Nice, France;6. Department of otorhinolaryngology, head and neck surgery, CHU de Toulouse/Oncopôle, Toulouse, France;7. Department of otorhinolaryngology, head and neck surgery, CHU, Bordeaux, France;8. Department of otorhinolaryngology, head and neck surgery, université Paris-Descartes, Assistance publique–Hôpitaux de Paris, Paris, France;9. Department of otorhinolaryngology, head and neck surgery, hôpital Xavier Bichat-Claude Bernard, CHU Paris Nord-Val de Seine, Assistance publique–Hôpitaux de Paris, Paris, France |
| |
| Abstract: | In the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched). |
| |
| Keywords: | COVID-19 COVID SARS-Cov-2 Head and neck cancer ENT |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
